EGFR and cancer: In vitro cell culture studies on A549 cells pointed to increased apoptotic and necrotic cancer cell death after treatment with nanoscale carriers with specific EGFR targeting motifs, most probably due to improved uptake of docetaxel-loaded cross-linked nanoparticles and the EGFR receptor internalization [76].